News
Poolbeg signs AI deal to advance human challenge data
CytoReason is used by five of the world’s top ten pharma companies, including Pfizer, Sanofi, Roche and Merck. The company deploys its AI modelling to assess immune cell behaviour.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
CytoReason is used by five of the world’s top ten pharma companies, including Pfizer, Sanofi, Roche and Merck. The company deploys its AI modelling to assess immune cell behaviour.